PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
15-Oct-2025 Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund Omnix Medical
14-Oct-2025 Actithera Secures Exclusive Rights to Innovative Covalent Chemistry Technologies from Weizmann Institute for Targeted Radiopharmaceutical Applications Actithera
14-Oct-2025 Ciliatech opens US subsidiary and plans clinical trials in glaucoma Andrew Lloyd Associates
14-Oct-2025 Final analysis of open-label extension (OLE) study of Fintepla®▼ (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy and Behavior UCB
14-Oct-2025 Iksuda to present IKS014 Phase 1 data at ESMO Iksuda
14-Oct-2025 Ona Therapeutics Appoints Oncology Drug Development Veteran Dr. Antoine Yver as Chair to Accelerate ADC Programs to Clinical Inflection Points Ona Therapeutics
14-Oct-2025 Actithera Secures Exclusive Rights to Innovative Covalent Chemistry Technologies from Weizmann Institute for Targeted Radiopharmaceutical Applications Actithera
14-Oct-2025 Peer Reviewed Publication Provides Evidence for Iron Dysregulation as a Driver of Dry AMD/GA and the Potential of Transferrin to Restore Iron Balance, Reinforcing PulseSight’s Therapeutic Strategy for PST-611 PulseSight Therapeutics
09-Oct-2025 PharmNovo secures CTA approval in Spain initiating Phase IIa proof-of-concept trial of PN6047 for neuropathic pain PharmNovo
09-Oct-2025 FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of CSCC Regeneron Pharmaceuticals, Inc.
09-Oct-2025 Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant Tensive
09-Oct-2025 Novakand Pharma provides an update on the ongoing reverse take over process Novakand Pharma
09-Oct-2025 Resolution Therapeutics announces upcoming presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2025 Resolution Therapeutics
09-Oct-2025 Orexa Announces Positive Interim Data for its Phase 2 Trial in the Prevention of Post-Operative Ileus Orexa
09-Oct-2025 Glen Clova Scientific Announces Clinical Advisory Board for its Immuno-Dermatology Pipeline Glen Clova Scientific
09-Oct-2025 Terumo Blood and Cell Technologies and Hemex Health join forces to improve outcomes for millions with sickle cell disease and other hemoglobin disorders Terumo BCT, Hemex Health
09-Oct-2025 Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030 Uniphar
09-Oct-2025 Glen Clova Scientific Announces Clinical Advisory Board for its Immuno-Dermatology Pipeline Glen Clova Scientific
08-Oct-2025 ANGLE plc - Appointment of Executive Chairman, proposed change of name and strategy update ANGLE plc
08-Oct-2025 AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors Sanofi